Skip to main content
CTEV
NYSE Finance

Ares Buys 115,579 Claritev Shares for $2.94 Million in Open Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$27.37
Mkt Cap
$459.312M
52W Low
$11.5
52W High
$61.22
52W Position info
138% above low
Off High info
55% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CTEV has more than doubled off its 52-week low of $11.5.

Summary

Ares-affiliated 10% owner entities bought 115,579 Claritev shares for $2.94 million on November 9-10, following the Q3 beat and a smaller Ares purchase in late October.


Key Events · Ownership and Investor Activity · CTEV

  • Ares Adds 115,579 Shares

    Ares-affiliated 10% owner entities bought 115,579 Class A shares in the open market on 2026-11-09 and 2026-11-10 for $2,935,628.61, at prices from $24.4221 to $26.1444.

  • Stake Rises to 2,049,518 Shares

    Post-transaction holdings are 2,049,518 shares, held indirectly through ASOF II Holdings I, ASOF II A (DE) Holdings I and ASOF III Holdings I.

  • Larger Than October Purchase

    This buy exceeds the 70,834 shares Ares bought for roughly $1.68 million on 2026-10-27, extending a pattern of accumulation.

  • Follows Q3 Beat and Raised Guidance

    The purchases came on 2026-11-09 and 2026-11-10, immediately after Claritev beat Q3 estimates and raised FY26 guidance on 2026-11-09.


Analysis · CTEV · Finance

Ares, Claritev's private-equity backer and a 10% owner, put another $2.94 million of real money into the stock across November 9-10, lifting its reported stake to 2,049,518 shares. The buying came right after the Q3 beat and raised guidance on November 9, and it is larger than the roughly $1.68 million Ares bought on October 27 — a sponsor adding to a position rather than trimming it. The caveat is that this is a financial owner, not an operator, so the read-through is support for the stock near current levels rather than an insider view on day-to-day execution.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTEV was trading at $27.37 on NYSE in the Finance sector, with a market capitalization of approximately $459.3M. The 52-week trading range was $11.50 to $61.22. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTEV - Latest Insights

CTEV
Nov 09, 2026, 10:48 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.86
Real-time Price: $27.37 info
Change: +$3.51 (+15%) info
Market Cap: $459.312M info
CTEV
Nov 09, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.71
Real-time Price: $27.37 info
Change: +$4.66 (+21%) info
Market Cap: $459.312M info
CTEV
Nov 09, 2026, 6:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $22.71
Real-time Price: $27.37 info
Change: +$4.66 (+21%) info
Market Cap: $459.312M info
CTEV
Aug 07, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.59
Real-time Price: $27.37 info
Change: -$5.22 (-16%) info
Market Cap: $459.312M info
CTEV
Aug 07, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.84
Real-time Price: $27.37 info
Change: +$0.530 (+2%) info
Market Cap: $459.312M info